In an era of change, labs are responding with new and innovative approaches and considering new angles from science and business perspectives. One Austin-based lab, focused on personalized medicine, merits special attention.
The California Initiative for the Advancement of Precision Medicine (CIAPM) is a national public entity formulated to ignite rational precision medicine research on popular diseases. It recently funded a study that will apply microsampling techniques. The upcoming multi-method, longitudinal, prospective cohort study will engage 200 patients with stable ischemic heart disease (IHD).
Laboratories: It’s time to get off the reimbursement treadmill.
You’ll expand your test menu and open your options when you add remote biofluid collection to your toolkit.
At Neoteryx, we research, develop, and commercialize simple, economical, and convenient microsampling devices for the collection and transportation of blood and other biological fluids.
In its May 2018 recommendation, the Food and Drug Administration includes the use of dried blood spot sampling for biomedical validation. The future of clinical chemistry and pharmacology will emphasize the use of microsampling.
Over the past few decades, a need for better and more efficient healthcare delivery has been on the rise. As a result, there has been an influx of devices and applications developed all in the hopes of delivering smarter healthcare.
In news from the world of veterinary medicinal product development, the State Scientific Control Institute of Veterinary Medicinal Products and Feed Additives in Lviv, Ukraine is moving forward with an innovative research project using Mitra® microsampling devices, powered by Volumetric Absorptive Microsampling (VAMS™) technology. The laboratory has developed a quick and accurate LC-MS/MS method for measuring florfenicol, an antibiotic used on farm animals.